CAS NO: | 1826843-81-5 |
包装 | 价格(元) |
1mg (10mg/mL * 100 μL in Aqueous solution) | 电议 |
5mg (10mg/mL * 500 μL in Aqueous solution) | 电议 |
生物活性 | Trastuzumab deruxtecan (DS-8201a) (solution) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan (solution) is composed of a humanized anti-HER2 antibody, an enzymaticallycleavablepeptide-linker, and atopoisomeraseI inhibitor. Trastuzumab deruxtecan (solution) can be used for the research of HER2-positive breastcancerand gastriccancer[1][2]. | ||||||||
体外研究 (In Vitro) | Trastuzumab deruxtecan (1 pM-10 nM; 5 days) (solution) inhibits the growth of HER2-positive KPL-4 cells, with an IC50of 109.7 pM[2]. Cell Viability Assay[2]
| ||||||||
体内研究 (In Vivo) | Trastuzumab deruxtecan (3 mg/kg; a single i.v.) (solution) shows antitumor activity against not only HER2-positive tumors but also HER2-negative tumors under the co-inoculated condition[2].
| ||||||||
Clinical Trial | |||||||||
性状 | Liquid | ||||||||
CAS 号 | 1826843-81-5 | ||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |